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Abstract
Background: The nematode Caenorhabditis elegans has emerged as a powerful system to study
biologic questions ranging from development to aging. The generation of transgenic animals is an
important experimental tool and allows use of GFP fusion proteins to study the expression of genes
of interest or generation of epitope tagged versions of specific genes. Transgenes are often
generated by placing a promoter upstream of a reporter gene or cDNA. This often produces a
representative expression pattern, but important exceptions have been observed. To better
capture the genuine expression pattern and timing, several investigators have modified large pieces
o f  D N A  c a r r i e d  b y  B A C s  o r  f o s m i d s  f o r  u s e  i n  the construction of transgenic animals via
recombineering. However, these techniques are not in widespread use despite the advantages
when compared to traditional approaches. Additionally, some groups have encountered problems
with employing these techniques. Hence, we sought identify ways to improve the simplicity and
reliability of the procedure.
Results: We describe here several important modifications we have made to existing protocols
to make the procedure simpler and more robust. Among these are the use of galK gene as a
selection marker for both the positive and negative selection steps in recombineering, the use of
R6K based plasmids which eliminate the need for extensive PCR product purification, a means to
integrate the unc-119 marker on to the fosmid backbone, and placement of homology arms to
commonly used GFP and TAP fusion genes flanking the galK cassette which reduces the cost of
oligos by 50%.
Conclusion: We have made several significant changes that allow the production of C. elegans
transgenes from a commercially available fosmid library in a robust and streamlined manner. These
changes make the technique more attractive especially to small academic labs unfamiliar with
recombineering.
Background
The generation of transgenic animals in model systems
such as Caenorhabditis elegans has created dramatic
changes in the ability of researchers to approach biologic
questions [1]. It is relatively straightforward to create and
use a transgenic animal to investigate the timing and pat-
tern of gene expression, express epitope-tagged versions of
genes, or test the effects of gene mis-expression.
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Traditionally, constructs used for creation of a GFP fusion
gene or epitope-tagged version of a gene were drawn from
regions of cloned genomic DNA which were known to res-
cue mutants of the specific gene [1]. As the availability of
RNAi, microarrays, and other approaches which are based
upon the worm genomic sequence instead of classical
mutants has increased, a need to create transgenes in other
ways has developed. For these genes, a region 5' of the
gene is often isolated via PCR and then used as a promoter
[2,3]. This approach has been further simplified by the
construction of a large number of vectors by the Fire lab
and later by the generation of the C. elegans promoterome
[1,2,4,5]. However, the decision about the exact length
and location of the promoter is more often driven by arbi-
trary decisions about the size (i.e. 2–3 kb) or convenient
restriction sites than sequence analysis. As a result, it is dif-
ficult to know if the GFP expression pattern created by a
selected promoter reflects the true expression pattern of
the gene in vivo [1].
To generate transgenes that are more likely to reflect the in
vivo expression timing and pattern, interest in generating
transgenics using the larger regions of genomic DNA car-
ried by either fosmids or BACs (bacterial artificial chro-
mosomes) is growing [5-7]. This approach carries the
advantage of using 30–300 kb of genomic DNA in the
construction of a transgene so it is likely that all or most
of the promoter and enhancer elements are included.
Additionally since the genomic DNA for the gene is
included, additional complexities such as alternative
splicing, multiple transcription start sites, and regulation
by 3' UTR sequences or microRNA can also occur.
For this approach to become a standard technique within
the C. elegans community, approaches need to be devel-
oped to make the modification of fosmids and BACs
quick and robust for the novice. Two recent publications
have begun to lay the groundwork for this to occur [6,7].
The first described the modification of C. elegans fosmids
using homologous recombination in E. coli (recombineer-
ing) using PCR generated DNA fragments [6]. The crea-
tion of a transgene occurred through a two-step procedure
where first a tetA-rpsL  cassette (RT cassette) flanked by
homology arms is inserted at the desired location and
then in a second step the cassette is replaced by the desired
DNA, such as GFP, flanked by the same homology arms.
This technique allows the insertion of essentially any
sequence at any site in the gene. The second paper
described the modification of BACs from the related nem-
atode species Caenorhabditis briggsae also by the use of
recombineering [7]. In this protocol, a GFP fusion gene is
created by inserting GFP at the C-terminus of a gene of
interest along with a flanking kanamycin resistance cas-
sette via a single round of recombineering with a PCR
product flanked by homology arms. The BAC is also pre-
pared for use as a transgene by insertion of the unc-119
gene via recombineering. The addition of the unc-119
gene provides an easily visualized selectable marker as this
DNA is able to rescue the size, body shape, mobility, and
starvation resistance defects present in unc-119 mutants
[8]. Each approach has strengths and weaknesses for the
routine generation of transgenic worms [5].
We have furthered their work by developing a streamlined
series of procedures and accompanying vectors to allow
the simple and reliable generation of transgenes ready for
the transformation of worms by bombardment or micro-
injection. Specifically, we focused on the use of C. elegans
genomic DNA cloned into a commercially available fos-
mid library (Geneservice Ltd., Cambridge, UK). We then
developed tools that will allow the robust and efficient
generation of either FLAG-GFP or TAP fusion genes by
four important changes. First, we utilized the more robust
galK gene for positive and then negative selection during
recombineering [9]. Second, we constructed plasmids for
galK utilizing the R6K origin which is unable to replicate
in the E. coli strain used for recombineering and mini-
mizes the amount of processing of the PCR products used
[10]. Third, we built homology arms for both GFP and N
and C-terminal TAP tags into the galK cassette so that a
single pair of oligos can be used for the generation of PCR
products for each step. The oligos used for recombineer-
ing are long and require purification prior to use so the
need for one pair instead of two reduces either the labor
or cost involved in procuring the oligos. Finally, we devel-
oped a protocol for adding the unc-119 gene to the fosmid
backbone through cre-lox mediated recombination [11].
The final fosmid product can then be used directly for the
generation of transgenic nematodes.
Results
We sought to use the C. elegans fosmid library and recom-
bineering for the routine generation of transgenes and
subsequent creation of transgenic worms. Two techniques
have been described using recombineering in C. elegans
with one using a BAC library generated from the related
nematode species C. briggsae while the other used the fos-
mid library followed by microinjection of the modified
plasmids [6,7]. We initially used the protocol described by
Dolphin et. al. to successfully generate several daf-12
transgenes (data not shown) (Additional files 1, 2, and 3).
During this process we identified several ways to optimize
and simplify the protocol for recombineering and trans-
genic animal creation.
The plasmid template used for the generation of the selec-
tion/counter-selection cassette by PCR, pBAC-RT, is able
to replicate in the SW106 bacterial strain used for recom-
bineering. Consequently, this template needs to be
destroyed prior to electroporation either by DpnI diges-BMC Developmental Biology 2008, 8:119 http://www.biomedcentral.com/1471-213X/8/119
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tion or as suggested by Dolphin et. al. through the use of
a restriction fragment as the PCR template [6]. As pBAC-
RT is constructed on a BAC vector backbone, it is a very
low copy number plasmid, and we experienced difficulty
in purifying sufficient DNA to digest and gel purify the
fragment containing the RT cassette. To address this diffi-
culty, we subcloned the RT cassette from pBAC-RT into
the pMOD4 vector (Epicentre Biotechnologies, Madison,
WI). pMOD4 uses the R6K replication origin which
requires the π protein for replication in E. coli. The result-
ing plasmid pMOD4 RT has the advantages of having a
higher copy number than pBAC-RT which simplifies DNA
purification and of being unable to replicate in the SW106
bacterial strain. Even when >100 ng. of pMOD4 RT DNA
was electroporated into SW106 no tetR colonies were
obtained (data not shown). As a result, PCR products used
for recombineering do not need to be digested with DpnI
or be extensively purified prior to use.
For C. elegans experiments most transgenes consist of GFP
fusions constructed to either identify the location and
timing of gene expression and/or to visualize the cellular
localization of the protein. To construct a GFP fusion
transgene using the method of Dolphin et. al. two pairs of
long oligonucleotides need to be ordered and purified for
the generation of a transgene [6]. The first set anneal to the
RT cassette and carry 50 base pair homology arms specific
for the gene of interest. The second set anneals to GFP and
carry the same homology arms. If these are purchased
from commercial companies the cost of these oligos is not
insignificant especially if multiple transgenes are to be
generated. To facilitate the construction of GFP fusion
genes, we inserted oligos with 50 base pair homology
arms for GFP into pMOD4 RT to generate pMOD4 RT-G
(Figure 1, Additional files 1, 2, and 3). The presence of
these homology arms allows a single set of oligos to be
used for the amplification of the RT cassette and GFP (Fig-
ure 1). This reduces the cost for oligos by half compared
with the prior technique.
During the construction of pMOD4 RT and daf-12 trans-
genes using the RT cassette we found two limitations of
the RT cassette. First, the RT cassette appears to be some-
what toxic to E. coli as pMOD4 RT could only be main-
tained in the JM109λpir strain where it is a low copy
number plasmid instead of the EC100pir-116 strain which
increases the copy number of R6K based plasmids to
~250. This toxicity may contribute to some of the difficul-
ties we experienced with positive and negative selection of
fosmids carrying the cassette. Second, the RT cassette
involves separate genes for positive and negative selection
during recombineering [12]. This property may increase
the background during negative selection as mutations in
the gene involved would be silent until the bacteria are
plated on selective media [9]. These mutations are most
likely introduced during PCR amplification as 106 ampli-
fication of the template would be expected to produce ~2–
6% of products with mutations for proofreading polymer-
ases and up to 25% for Taq-proofreading polymerase
blends [13]. Hence, any toxicity of the cassette would
facilitate selection of mutated, less toxic clones. To
address these two concerns we experimented with the use
of the galK gene for positive and negative selection during
recombineering [9]. To facilitate the use of galK, we trans-
ferred the galK gene to the pMOD4 plasmid and added
GFP homology arms for use during recombineering (Fig-
ure 1, Additional files 1, 2, and 3).
We initially compared the use of pMOD4 RT-G and
pMOD4 galK-G by constructing a GFP fusion at the N-
term of the K10C2.4 gene which encodes a member of the
fumarylacetoacetate hydrolase family (Figure 2) [14].
Prior attempts to create a GFP reporter using the pro-
moterome library clone were unsuccessful perhaps due to
a lack of important promoter elements in the promoter
clone (A.F., unpublished data). We found that the RT and
galK cassettes can be easily inserted into a fosmid carrying
K10C2.4 by recombineering (Figure 2 lanes 2 and 7). We
then used a PCR fragment carrying FLAG-tagged GFP to
replace either the RT or galK cassette via a second round of
recombineering. Colonies with successful substitution of
FLAG-GFP were identified by using selective media. We
found the galK cassette was more robust than the RT cas-
sette as 4/4 colonies created with the galK cassette and 0/
4 colonies created with the RT cassette (Figure 2 lanes 3, 4,
8. and 9) carried FLAG-GFP by PCR. PCR analysis of a fur-
ther 48 clones revealed 40/48 colonies created with the
galK cassette and 0/48 colonies created with the RT cas-
sette carried FLAG-GFP after selection (Table 1).
The source of this difference appears to be at least in part
due to weaker negative selection from the RT cassette as
revealed by analysis of colonies obtained after a no PCR
product control electroporation. This control was con-
ducted similarly to the second recombineering step but no
FLAG-GFP PCR product was added prior to electropora-
tion. PCR analysis of 48 colonies for the galK and RT cas-
settes revealed that 23/48 galK cassette bacteria still had at
least part of the cassette whereas 46/48 RT colonies still
had a cassette detectable by PCR (Table 1). This suggests
that a significant number of bacteria with the RT cassette
are still able to grow despite negative selection. Further,
addition of the FLAG-GFP PCR product to the electropo-
ration resulted in a noticeable increase in colonies from
bacteria with the galK cassette but not from bacteria with
the RT cassette (Table 1). These counts were performed in
parallel and included bacteria from undiluted, 1:10
diluted, and 1:100 diluted samples plated from a single
experiment. Together, the greater number of total colonies
obtained from bacteria with the galK cassette along withBMC Developmental Biology 2008, 8:119 http://www.biomedcentral.com/1471-213X/8/119
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Diagram of pMOD4-RT-G, pMOD4-galK-G, and pMOD4-galK-GT Figure 1
Diagram of pMOD4-RT-G, pMOD4-galK-G, and pMOD4-galK-GT. The pMOD4-RT-G plasmid consists of the RT cas-
sette flanked by 50 nucleotide regions identical to the 5' and 3' ends of FLAG-GFP (green) while pMOD4-galK-G consists of the 
galK cassette flanked by the same sequences. pMOD4-galK-GT consists of the galK cassette flanked by both the FLAG-GFP 
homology regions and 50 nucleotide regions identical to the 5' and 3' ends of N-terminal and C-terminal TAP (blue and orange, 
respectively). Both plasmids utilize the R6K-based pMOD4 backbone which is unable to replicate in SW106.
pMOD4 GalK-G
1381 bp GalK
pMOD4 RT-G
2548 bp ompF rpsL tetA
pMOD4 GalK-GT
1612 bp
pMOD4
2090 bp
GalKBMC Developmental Biology 2008, 8:119 http://www.biomedcentral.com/1471-213X/8/119
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the more effective negative selection might lead to the
greater effectiveness of the galK cassette in recombineering
as the significant number of true positives could now out-
number the relatively small number of false positives.
Consistent with this, PCR analysis of the galK colonies
electroporated with the FLAG-GFP PCR product revealed
that only 3/48 colonies retained the galK cassette whereas
40/48 colonies correctly have the FLAG-GFP tag instead.
To facilitate the use of modified fosmids for the creation
of transgenic animals we exploited the loxP site in the fos-
mid backbone as a means to quickly insert selectable
markers. The SW106 bacterial strain used for recom-
bineering also carries a transgene that expresses the cre
recombinase under the control of the arabinose inducible
araBAD promoter [9]. We constructed the plasmid pLoxP
unc-119 which carries the genomic DNA that rescues the
unc-119 mutant and a loxP site on the pMOD4 vector
backbone (Figure 3A, Additional files 1, 2, and 3). This
plasmid is unable to replicate in SW106 due to the R6K
replication origin. We were able to integrate this plasmid
into fosmids in SW106 by using electroporation followed
by recovery in LB containing arabinose (Figure 3B and
3C). Fosmids with successful integration were identified
by selection on LB plates containing chloramphenicol and
ampicillin. The latter antibiotic selects for integration of
the ampicillin resistance gene carried on the pMOD4
backbone into the fosmid loxP site. While the cre-lox
recombination event is reversible, we have not found this
to be a significant problem due to continued selection for
ampicillin resistance and the use of the EPI300 bacteria
strain, which lacks cre recombinase, for large-scale growth
and long-term storage of modified fosmids.
We tested whether the K10C2.4::GFP  transgene created
was functional by creating transgenic animals via biolistic
bombardment. We obtained a mix of transgenic animals
carrying extrachromosomal arrays and integrated trans-
genes. Analysis of >15 lines revealed a similar pattern of
GFP expression in the intestine and hypodermis (Figure
4A and data not shown). Additionally, the transgene pro-
duced a K10C2.4:GFP fusion protein in vivo based on two
lines of evidence. First, RNAi directed against either GFP
or K10C2.4 resulted in a loss of GFP expression as seen by
fluorescence microscopy (Figure 4B and 4C). Second,
western blotting using α-FLAG antibodies, which detect a
FLAG epitope at the start of GFP, identified a 76 kD pro-
tein consistent with a K10C2.4:GFP fusion protein, and
RNAi directed at GFP or K10C2.4 result in the loss of this
protein (Figure 4D). Together these data indicate the abil-
ity of recombineering to produce transgenes capable of
producing fusion proteins and to introduce new epitope
tags into target genes.
Our work with K10C2.4 suggested that the galK cassette
was more robust for the negative selection step than the
RT cassette. To explore this observation, we created FLAG-
GFP fusion genes for the dod-22  and  myo-3  genes. We
found that similarly to K10C2.4, the galK cassette proved
more reliable in head-to-head testing with the RT cassette
with regards the isolation of correctly modified fosmids
after negative selection (Figure 5, lanes 3 and 4 compared
to lanes 7 and 8). With the screening of 48 additional col-
onies, we found 1/48 dod-22 and 2/48 myo-3 colonies car-
rying FLAG-GFP for colonies created with the RT cassette
whereas for the galK cassette 46/48 dod-22 and 46/47 myo-
3 colonies carried FLAG-GFP (Table 1). Remarkably, we
found that colonies carrying FLAG-GFP could also be
obtained with induced competent cells stored at -80°C for
a full year (Table 1).
Besides the production of GFP fusion proteins, an increas-
ing number of papers in C. elegans research are describing
the use of transgenic worm strains for proteomic studies
aimed at identifying protein interaction partners [15-19].
One approach has been to use the TAP tag which consists
of a combination of protein-A and calmodulin binding
peptide epitopes which allow the purification of tagged
Table 1: Genotype of colonies isolated after recombineering
Gene Cassette PCR product electroporated Colonies Obtained GFP + colonies Cassette + colonies
K10C2.4 galk FLAG-GFP 714 40/48 3/48
K10C2.4 galk None 85 0/48 23/48
K10C2.4 RT FLAG-GFP 55 0/48 46/48
K10C2.4 RT None 81 0/48 46/48
dod-22 galk FLAG-GFP N.D. 46/48 N.D.
dod-22 RT FLAG-GFP N.D. 1/48 N.D.
myo-3 galk FLAG-GFP N.D. 46/47 N.D.
myo-3 RT FLAG-GFP N.D. 2/48 N.D.
dod-22
(Frozen 1 year)
galk FLAG-GFP N.D. 16/48 N.D.
myo-3
(Frozen 1 year)
galk FLAG-GFP N.D. 18/48 N.D.BMC Developmental Biology 2008, 8:119 http://www.biomedcentral.com/1471-213X/8/119
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proteins at high purity via the use of two successive puri-
fication steps [20]. The TAP tag has been successfully used
in C. elegans to purify the unc-29 acetylcholine receptor
subunit along with multiple interacting proteins that were
subsequently identified by mass spectrometry [21]. To
facilitate the creation of TAP-tagged transgenes we modi-
fied pMOD4 galK-G to add regions complementary to
either the N-terminal or C-terminal version of the TAP tag.
The resulting plasmid, pMOD4 galK-GT, allows a single
set of oligos to be used for the generation of the tagged
fosmid through sequential rounds of recombineering
(Figure 6).
Discussion
A streamlined procedure for transgene production
We describe a modified protocol and accompanying vec-
tors that can be used to easily produce fosmid-based trans-
genes for the generation of transgenic C. elegans. Our
Production of FLAG-GFP modified fosmids with pMOD4-galK-G Figure 2
Production of FLAG-GFP modified fosmids with pMOD4-galK-G. The fosmid carrying the K10C2.4 gene was modified 
using positive and negative selection using PCR amplified cassettes from the indicated plasmids. The effectiveness of fosmid 
modification was monitored via PCR using the indicated oligo sets. Lane 1, 2, 3, 4, 5, 6, 8 and 9 FLAG-GFP F and FLAG-GFP R; 
Lane 7 RT screen F and RT screen R.
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protocol involves three steps which are all carried out in
the SW106 bacterial stain.
In the first step, the galK gene is integrated into the desired
site in the fosmid to be modified through recombineering
with a PCR product carrying galK flanked by homology
arms complementary to the target fosmid (Additional
files 1, 2, and 3). We have improved this step relative to
prior techniques via the integration of homology regions
for either FLAG-GFP or a TAP tag into the galK cassette.
This allows a single set of oligos to be used for the first and
second steps of fosmid modification and lowers the cost
of fosmid modification by 50%. The integration of GFP
homology arms into the RT cassette has also been recently
described by Bamps and Hope [5]. This modification is
especially important if the technique is to be scaled up to
genome-wide coverage. We further simplify the first step
through the use of a galK cassette carried on an R6K-based
vector which is unable to replicate in the SW106 bacterial
strain. This improvement eliminates the need to either
DpnI digest nor extensively purify the PCR product used
for recombineering.
In the second step, the galK cassette is replaced with tags
such as GFP or TAP which are then fused with the gene of
interest on the fosmid (Additional files 1, 2, and 3). The
success of this step hinges on the effectiveness of the neg-
ative selection strategy used to identify correctly modified
fosmids from those that are unmodified. We found that
the galK cassette was more reliable than the previously
described RT cassette in head to head testing. Similar
results have also been found by another lab (P. Moroni,
personal communication). This may be due to the galK
gene product serving as the target of both positive and
negative selection instead the two separate genes in the RT
cassette which are involved in each step [9]. The larger size
of the RT cassette also required the use a lower fidelity
polymerase, i.e. a Taq/proof-reading polymerase versus a
proof-reading polymerase alone, for efficient amplifica-
tion which may serve as a source of mutations in the cas-
Addition of a selectable marker with pLoxP unc-119 Figure 3
Addition of a selectable marker with pLoxP unc-119. (A) Map of pLoxP unc-119 showing the ampicillin resistance gene 
(ampR), R6K replication origin, and loxP site. (B) Integration of the pLoxP unc-119 plasmid into the fosmid carrying K10C2.4 as 
shown by PCR. The selected ampicillin-resistant colony (modified) carries both the unc-119 and R6K sequences from pLoxP 
unc-119 but absent in the parent fosmid which are detected via PCR with the indicated oligo sets. unc-119 unc-119 F and unc-
119 R; R6K R6K F and R6K R.
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Generation of transgenic animals with modified fosmids Figure 4
Generation of transgenic animals with modified fosmids. The modified fosmid carrying the K10C2.4:FLAG-GFP trans-
gene was introduced into the DP38 (unc-119(ed3)) strain via microparticle bombardment. (A) GFP expression seen in the 
transgenic worms. (B and C) GFP expression is reduced by treatment with GFP (B) or K10C2.4 (C) RNAi. (D) Detection of 
the FLAG-GFP transgene in RNAi treated worm extracts by western blotting with anti-FLAG antibodies. Equal loading was 
confirmed by blotting with anti-actin antibodies.
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sette that could interfere with the negative selection step.
Alternately, we have found that the RT cassette is some-
what toxic to bacteria which may lead to the selection for
mutations that decrease the effectiveness of negative selec-
tion. In contrast, for the galK cassette the positive selection
step and subsequent re-streaking on MacConkey agar
select for robust galK expression before galK is used in the
negative selection step. Additionally, our addition of the
FLAG-GFP or TAP homology regions into the galK cassette
may also increase the efficiency of recombineering by
increasing the length of the homology arms the PCR prod-
uct to a maximum of 100 bp on each end. However, we
have failed to see a qualitative difference between the 100
bp homology arm and a shorter FLAG-GFP only PCR
product with 50 bp homology arms when tested (data not
shown). It still may be possible that for a subset of genes
the 100 bp homology arms might make an important
contribution. Finally, it may be possible that subtle
changes in the protocol used by other groups may have a
significant impact on the success of recombineering with
Comparison of fosmid modification using pMOD4-galK-G with pMOD4-RT-G Figure 5
Comparison of fosmid modification using pMOD4-galK-G with pMOD4-RT-G. Fosmids carrying the dod-22 (top) or 
myo-3 genes (bottom) were modified to generate FLAG-GFP fusion genes through positive and negative selection using either 
the galK or RT cassette. The effectiveness of fosmid modification was monitored via PCR using the indicated oligo sets. Lane 1, 
2, 3, 4, 7 and 8 FLAG-GFP F and FLAG-GFP R; Lane 5 and 6 RT screen F and RT screen R.
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Generation of TAP modified fosmids with pMOD4-galK-GT Figure 6
Generation of TAP modified fosmids with pMOD4-galK-GT. Fosmids carrying dod-22 (top) or srp-6 genes (bottom) 
were modified to generate a C-terminal (dod-22) and N-terminal (srp-6) TAP fusion transgene. After modification, pLoxP unc-
119 was then integrated into the fosmid backbone. The effectiveness of fosmid modification was monitored via PCR using the 
indicated oligo sets. Lane 1 and 2 C-term TAP F and C-term TAP R (top) and N-term TAP F and N-term TAP R (bottom); 
Lane 3 and 4 primers derived from the sequences flanking the insertion site which produce an up-shift following insertion of 
the tag (sequence available upon request); Lane 5 and 6 unc-119 F and unc-119 R.
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the RT cassette as some groups have reported higher effi-
ciency rates with it [6].
In the third step a selectable marker for the generation of
transgenic worms is added to the fosmid (Additional files
1, 2, and 3). This creates a marker in cis and directly linked
to the modified fosmid. For the selectable marker, we
chose the widely used unc-119 marker that is compatible
with both microinjection and biolistic bombardment [8].
Bombardment is particularly useful as significant num-
bers of transgenic lines can be generated by a single trial
and even inexperienced personnel can create transgenics
(data not shown).
As a result of our modifications, the entire procedure can
be accomplished from start to production of a transgenic
animal in a few weeks even by members of the lab who
have a grasp of lab basic techniques but are not expert in
molecular biology or microbiology.
Applications
Our lab has used this procedure to generate both GFP
transgenes to examine gene expression pattern and
response to RNAi [14]. We have also used this procedure
to generate TAP transgenes for proteomic studies, but
these transgenic animals could also be used for chromatin
or RNA immunoprecipitation assays as well (Figure 6 and
not shown). It might be possible to adapt this technique
to liquid culture as means to create transgenes in a high
throughput manner. Beyond the intended uses of this
technique, we have found that recombineering provides
the flexibility to generate alternate vectors at a later time.
Specifically, the induced, competent bacteria carrying the
galK intermediate can be stored for later use even months
to a year later (Table 1). Oligos carrying homology arms
to the target gene can then be used to quickly add other
tags generated by PCR. For example, we have been able to
generate a transgene carrying a modified TAP tag which
has been reported to produce higher purified protein
yields in Drosophila to conduct head-to-head tests [22].
Making this change only requires a few days of work to
reach the stage of generating new transgenic animals.
Finally while our work focused on applications in C. ele-
gans, it is likely that some of these reagents can be used in
the construction of modified BACs or fosmids for other
experimental systems.
Problems encountered
During construction of modified fosmids, we encoun-
tered problems with the modification of srp-6 and dod-22.
These fosmids are similar in that both contain multiple
genes that are highly similar at the sequence level. For
example, the WRM0627aH02 fosmid contains both srp-5
and srp-6 and the WRM066cB09 fosmid contains dod-22
and K10D11.2. For srp-6 we discovered a rearrangement
during the initial transformation into SW106. This was
easily detected via PCR using primers that anneal 50–100
nucleotides away on the genomic sequence flanking the
desired modification site. For dod-22 we found that the
galK cassette integrated into another site on the fosmid.
This was similarly detected by PCR using flanking oligos.
Both of these difficulties could be overcome by diligence
during the screening of isolated colonies and are likely
due to the presence of highly similar sequences that could
lead to spurious recombination events. To guard against
moving forward with an incorrect fosmid, we have rou-
tinely screened colonies with both cassette-specific and
flank sequence-specific oligos to ensure the right insert
and right site. The flanking oligos are also useful for the
sequencing of the resulting fosmids.
Conclusion
We have modified existing recombineering protocols to
create a simpler and more robust method of generating
transgenes for use in the construction of transgenic
worms. The approach and vectors will be of benefit espe-
cially to smaller academic labs looking to begin to use fos-
mid-based transgenes.
Methods
Strains
Recombineering in E. coli was performed using the SW106
(mcrA  Δ(mrr-hsdRMS-mcrBC)  ΔlacX74 deoR endA1
araD139 Δ(ara, leu) 7697 rpsL recA1 nupG φ80dlacZΔM15
[λc1857 (cro-bioA)<>Tet] (cro-bioA)<>araC-PBAD  Cre
ΔgalK) strain which carries the λred homologous recom-
bination genes under the control of a temperature sensi-
tive  λ repressor as well as an arabinose inducible cre
recombinase (Table 2) [9]. Fosmids were grown before
and after recombineering in the EPI300 (F-mcrA Δ(mrr-
hsdRMS-mcrBC)  φ80dlacZΔM15  ΔlacX74 recA1 endA1
araD139 Δ(ara, leu)7697 galU galK λ- rpsL nupG trfA tonA)
strain which allows the fosmid copy number to be regu-
lated via the addition of a chemical inducer (Epicentre
Biotechnologies, Madison, WI) (Table 2). Plasmids
derived from pMOD4 (Epicentre Biotechnologies, Madi-
son, WI) were grown in the EC100D pir-116  (F- mcrA
Δ(mrr-hsdRMS-mcrBC)  φ80d  lacZΔM15  ΔlacX74  recA1
endA1 araD139 Δ(ara, leu)7697 galU galK λ- rpsL nupG pir-
116(DHFR)) (Epicentre Biotechnologies, Madison, WI)
or JM109λpir (F' traD36 proA+B+lacIq Δ(lacZ)M15/Δ(lac-
proAB) glnV44 e14-gyrA96 recA1 relA1 endA1 thi hsdR17
λpir) strains due to the R6K origin which requires the pir
protein for replication (Table 2) [10]. Transgenic nema-
todes were created using the DP38 (unc-119(ed3) III)
strain obtained from the Caenorhabditis Genetics Center
which is supported by the NIH.
Plasmids
pBAC-RT was obtained from Dr. Colin Dolphin [12].
pMOD4-RT was generated by digesting pBAC-RT with
EcoRI and ApaI and ligating this fragment into pLoxP. TheBMC Developmental Biology 2008, 8:119 http://www.biomedcentral.com/1471-213X/8/119
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resulting plasmid was digested with XbaI and EcoRI and
the fragment carrying the RT cassette was ligated into
pMOD4 (Epicentre Biotechnologies, Madison, WI) (Table
2). pMOD4-RT could only propagated in JM109λpir
where the plasmid is low copy number. pMOD4-RT-G
was created from pMOD4-RT by insertion of oligos con-
taining 50 bp regions of homology to the N and C-termi-
nal ends of FLAG-GFP (sequence available on request).
This resulted in an RT cassette that was slightly larger than
that generated via PCR by Dolphin et. al. [6]. pMOD4
galK-G was constructed from pGalK (a gift of Drs. Soren
Warming and Neal Copeland) by insertion of oligos con-
taining 50 bp regions of homology to the N and C-termi-
nal ends of FLAG-GFP into the plasmid (sequence
available on request). The oligos and galK cassette were
then removed as an XbaI-Acc65I fragment and ligated into
pMOD4 digested with XbaI and Acc65I. pMOD4 galK-GT
was constructed from pMOD4 galK-G by insertion of oli-
gos containing 50 bp regions of homology to the N and
C-terminal ends of the N and C-terminal TAP tags from
the plasmids pBS1761 and pBS1479, respectively (Table
2) [20,23]. pMOD4 GFP was generated by cloning a PstI-
EcoRI fragment from pFLAG-GFP Daf-12 into pMOD4
digested with PstI and EcoRI. This fragment contains a 5'
FLAG epitope fused to GFP from pPD117.01 (a gift from
Dr. Andy Fire) and the N-terminal 328 amino acids of daf-
12 (Table 2). pLoxP unc-119 was generated by inserting an
oligo containing a loxP site into pMOD4 (sequence avail-
able on request) and digesting the resulting plasmid with
XbaI and ApaI. The unc-119  gene was excised from
pDP#MM016b as an XbaI-ApaI fragment and inserted
into pLoxP (Table 2) [24].
The following fosmids were obtained from Geneservice
Ltd. (Cambridge, UK): WRM066cB09 – dod-22,
WRM0615cC09 – K10C2.4, WRM061015 – myo-3,
WRM0627aH02 – srp-6 (Table 2).
Recombineering
Electrocompetent SW106 cells were made by growing a 5
mL overnight culture in LB broth with chloramphenicol
(12.5 μg/mL) (Additional files 1, 2, and 3). 1 mL was then
inoculated into 100 mL of LB with chloramphenicol in a
2 L flask and grown to an OD600 0.6–0.8. 50 mL of the cul-
ture was then transferred to a sterile 250-mL flask and
induced by gently shaking (100 rpm) in a water bath at
42°C for 20 minutes. In control experiments we found
that use of a shaking water bath was critical for effective
induction. These can be often purchased used for much
less than new equipment. The non-induced control was
shaken gently for the same amount of time at 32°C, and
then both cultures were incubated on ice for 15 minutes.
Each culture was then pelleted and washed twice in 50 mL
ice-cold 10% glycerol. All but ~500 μl of each supernatant
was aspirated and the pellets were resuspended by gentle
vortexing. 100 μl aliquots were then stored at -80°C until
use.
Electroporation was performed using PCR fragments gen-
erated from pMOD4 RT-G, pMOD4 galK-G, or pMOD4
galK-GT using an Eppendorf 2510 electroporator (Eppen-
dorf, Westbury, NY) at 1350 volts in 0.1 cm gap cuvettes.
Oligos for PCR consisted of the FLAG-GFP or TAP
sequences fused 3' to 50 bp homology arms derived from
the desired site of integration in the target gene (Table 3).
PCR products were routinely gel purified but not DpnI
digested. For the RT cassette, 150 ng of PCR product was
used and the cells were recovered in 1 mL of SOB [-MG]
for 1–3 hours before washing twice in M9 buffer. At the
end, the induced cells were brought up in 1 mL and the
non-induced cells in 0.5 mL M9. Serial dilutions of 1:1,
1:10, and 1:100 were plated on LB plates with tetracycline
(5  μg/m) and chloramphenicol (12.5 μg/mL). For the
galK cassette a similar protocol was followed, except after
electroporation the cells were recovered in LB for 4.5
hours and they were plated on MOPS minimal media
(Teknova Inc., Hollister, CA) supplemented with 0.2%
Table 2: Strain and vector availability
Plasmids Source Available at
Fosmid clone Geneservice Ltd. Geneservice
pGalK [9] NCI-Frederick
pMOD4-RT-G This work Addgene
pMOD4-galK-G This work Addgene
pMOD4-galK-GT This work Addgene
pLoxP- unc-119 This work Addgene
pMOD4-GFP This work Addgene
Bacteria
SW106 [9] NCI-Frederick
EPI300 Epicentre Biotechnologies Epicentre
EC100D pir-116 Epicentre Biotechnologies Epicentre
JM109λpir [10] Cloning Vector CollectionBMC Developmental Biology 2008, 8:119 http://www.biomedcentral.com/1471-213X/8/119
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galactose, leucine (45 mg/L), biotin (1 mg/L), and Cm
(12.5 μg/mL). The plates were incubated at 32°C for 3–4
days and then 4 colonies for RT and galK cassettes were
each streaked onto new plates, for RT the same type of
plates were used, while galK was streaked onto MacCo-
nkey agar plates containing galactose and chlorampheni-
col (12.5 μg/mL). These plates were incubated at 32°C for
3 days. 4 colonies of each were picked and used to make
5 mL liquid cultures in LB with tetracycline (5 μg/mL) for
RT and chloramphenicol (12.5 μg/mL) for both. 0.5 μL of
each overnight culture was used for PCR to confirm inser-
tion of the cassette.
For the second recombineering process, PCR-generated
fragments from pMOD4 FLAG-GFP, pBS1761 (N-term
TAP), or pBS1479 (C-term TAP) were generated using the
same oligos used in the first round or using shorter GFP or
TAP-specific oligos (Table 3). The products (100 ng.) were
electroporated into induced competent SW106 cells pre-
pared as above. The electroporation was done as above,
except bacteria containing the RT cassette were recovered
in SOC and plated on NSLB agar plates containing chlo-
ramphenicol (12.5 μg/mL) and streptomycin (500 μg/
mL) and those containing the galK cassette on MOPS min-
imal media plates containing 0.2% 2-deoxy-galactose
(DOG) and 0.2% glycerol in addition to leucine (45 mg/
L), biotin (1 mg/L), and chloramphenicol (12.5 μg/mL)
[12]. The plates were incubated for 3–5 days. While we
followed relative colony counts on the induced and un-
induced plates, we found that there was not always a
direct correlation between the counts and successfully
identifying clones with correctly modified fosmids. 4 col-
onies were used to make 5 mL overnight cultures in LB
with chloramphenicol (12.5 μg/mL) and these were used
for colony PCR as above to confirm that the cassette was
inserted. DNA sequencing using flanking oligos was also
used to verify correct modification of the fosmid.
Addition of the unc-119 selectable marker
To facilitate the identification of transgenic worms follow-
ing biolistic transformation, we inserted the unc-119 gene
into the fosmid backbone via cre-lox mediated recombi-
nation using the pLoxP unc-119 plasmid (Additional files
1, 2, and 3) [11,24]. pLoxP unc-119 carries the unc-119
gene on a R6K-based suicide vector that is unable to repli-
cate in the SW106 bacteria (data not shown). Recombina-
tion was accomplished by preparing competent SW106
bacteria carrying the modified fosmid followed by electro-
poration with 50 ng. pLoxP unc-119 as described above.
Following electroporation, bacteria were allowed to
recover in LB containing 0.1% arabinose for 1 hour. Aliq-
uots were plated on LB plates containing ampicillin (50
μg/mL) and chloramphenicol (12.5 μg/mL) which selects
for integration of pLoxP into the fosmid. The presence of
the unc-119 gene could also be verified via PCR (Table 3
and Figure 3).
Generation of transgenic worms
Fosmids modified through two rounds of recombineering
and addition of the unc-119 gene were isolated via mini-
prep using the FosmidMAX DNA purification kit (Epicen-
tre Biotechnologies, Madison, WI). This DNA was used to
electroporate the EPI300 bacterial strain which allows
library fosmids to be amplified by following the manufac-
turer's instructions (Epicentre Biotechnologies, Madison,
WI). Amplified fosmids were purified from 50 mL of cul-
ture using the same kit. We also used a Qiagen maxi-prep
kit (Qiagen Inc., Valencia, CA) but found significant
amounts of sheared DNA compared with the FosmidMAX
kit (not shown). 10 ug of fosmid DNA was used to trans-
form the DP38 unc-119(ed3)  mutant strain via gold
microparticle bombardment using a published protocol
[25]. Transgenic animals were identified via the rescue of
the unc-119 mutation by the rescue fragment carried on
the fosmid.
Table 3: Oligonucleotides used for PCR
Oligo Sequence
C-term TAP F ATGGAAAAGAGAAGATGGAAAAAG
C-term TAP R GGTTGACTTCCCCGC
FLAG-GFP F ATGGATTACAAGGACGATGACGATAAGATGAG
FLAG-GFP R CAAAGCTTGTGGGCTTTTGTATAG
N-term TAP F ATGGCAGGCCTTGCGC
N-term TAP R AAGTGCCCCGGAGGATGAGATTTTCT
R6K F CCTTAGAGGCTATTTAAGTTGCTG
R6K R GTACTAAGCTCTCATGTTTCAC
RT screen F ACGTTAACCGGGCTGCAT
RT screen R GCCGTCAATAAGTTCTGTCAA
unc-119 F CAAATCCGTGACCTCGACAC
unc-119 R CACAGTTGTTTCTCGAATTTGGBMC Developmental Biology 2008, 8:119 http://www.biomedcentral.com/1471-213X/8/119
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RNAi treatment was conducted using the feeding
approach. The K10C2.4 and GFP RNAi constructs have
been previously described [14,26]. Photomicrographs
were taken using an Olympus BX51 upright microscope
fitted with FITC filters for detection of GFP. All photos
were taken on the same day using the same camera set-
tings to allow direct comparison of images. Western blot-
ting was performed on worm extracts as previously
described [14]. Detection was performed using the anti-
FLAG antibody (Sigma-Aldrich, St. Louis, MO) followed
by incubation with an IR dye 800 donkey anti-mouse sec-
ondary antibody (Li-Cor Biosciences, Lincoln, NE). Equal
loading was confirmed by use of an anti-actin antibody as
previously described [14].
Authors' contributions
YZ conceived of the study, constructed plasmids, con-
ducted recombineering experiments, participated in data
analysis, and contributed to writing and editing the man-
uscript. LN constructed plasmids, conducted recom-
bineering experiments, and contributed to writing and
editing the manuscript. ALF conceived of the study, partic-
ipated in data analysis, and wrote the manuscript.
Additional material
Acknowledgements
We wish to thank Drs. S. Warming and N. Copeland for providing the 
SW106 bacterial strain and pGalK plasmid used in this work, Dr. C. Dol-
phin for providing the pBAC-RT plasmid and help with getting started with 
recombineering, and Dr. P. Moroni for helpful discussion.
This work was funded by NIH grant AG028977 to ALF and in part by a pilot 
project grant from the University of Pittsburgh OAIC (AG024827). The 
funding agencies played no role in the collection, analysis, or reporting of 
results.
References
1. Mello C, Fire A: DNA transformation.  Methods Cell Biol 1995,
48:451-482.
2. Fire A, Harrison SW, Dixon D: A modular set of lacZ fusion vec-
tors for studying gene expression in Caenorhabditis elegans.
Gene 1990, 93:189-198.
3. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC: Green flu-
orescent protein as a marker for gene expression.  Science
1994, 263:802-805.
4. Dupuy D, Li QR, Deplancke B, Boxem M, Hao T, Lamesch P, Sequerra
R, Bosak S, Doucette-Stamm L, Hope IA, Hill DE, Walhout AJ, Vidal
M: A first version of the Caenorhabditis elegans Promoter-
ome.  Genome Res 2004, 14:2169-2175.
5. Bamps S, Hope IA: Large-scale gene expression pattern analy-
sis, in situ, in Caenorhabditis elegans.  Brief Funct Genomic Pro-
teomic 2008.
6. Dolphin CT, Hope IA: Caenorhabditis elegans reporter fusion
genes generated by seamless modification of large genomic
DNA clones.  Nucleic Acids Res 2006, 34:e72.
7. Sarov M, Schneider S, Pozniakovski A, Roguev A, Ernst S, Zhang Y,
Hyman AA, Stewart AF: A recombineering pipeline for func-
tional genomics applied to Caenorhabditis elegans.  Nat Meth-
ods 2006, 3:839-844.
8. Praitis V, Casey E, Collar D, Austin J: Creation of low-copy inte-
grated transgenic lines in Caenorhabditis elegans.  Genetics
2001, 157:1217-1226.
9. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG:
Simple and highly efficient BAC recombineering using galK
selection.  Nucleic Acids Res 2005, 33:e36.
10. Penfold RJ, Pemberton JM: An improved suicide vector for con-
struction of chromosomal insertion mutations in bacteria.
Gene 1992, 118:145-146.
11. Kotzamanis G, Cheung W, Abdulrazzak H, Perez-Luz S, Howe S,
Cooke H, Huxley C: Construction of human artificial chromo-
some vectors by recombineering.  Gene 2005, 351:29-38.
12. Stavropoulos TA, Strathdee CA: Synergy between tetA and rpsL
provides high-stringency positive and negative selection in
bacterial artificial chromosome vectors.  Genomics 2001,
72:99-104.
13. Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Ishioka
C, Friend SH, Iggo R: A rapid PCR fidelity assay.  Nucleic Acids Res
1994, 22:3259-3260.
14. Fisher AL, Page KE, Lithgow GJ, Nash L: The Caenorhabditis ele-
gans K10C2.4 Gene Encodes a Member of the Fumarylace-
toacetate Hydrolase Family: A CAENORHABDITIS
ELEGANS MODEL OF TYPE I TYROSINEMIA.  J Biol Chem
2008, 283:9127-9135.
15. Cheeseman IM, Niessen S, Anderson S, Hyndman F, Yates JR III,
Oegema K, Desai A: A conserved protein network controls
assembly of the outer kinetochore and its ability to sustain
tension.  Genes Dev 2004, 18:2255-2268.
16. Duchaine TF, Wohlschlegel JA, Kennedy S, Bei Y, Conte D Jr, Pang K,
Brownell DR, Harding S, Mitani S, Ruvkun G, Yates JR III, Mello CC:
Functional proteomics reveals the biochemical niche of C.
elegans DCR-1 in multiple small-RNA-mediated pathways.
Cell 2006, 124:343-354.
17. Polanowska J, Martin JS, Garcia-Muse T, Petalcorin MI, Boulton SJ: A
conserved pathway to activate BRCA1-dependent ubiquit-
ylation at DNA damage sites.  EMBO J 2006, 25:2178-2188.
18. Luke-Glaser S, Roy M, Larsen B, Le BT, Metalnikov P, Tyers M, Peter
M, Pintard L: CIF-1, a shared subunit of the COP9/signalosome
and eukaryotic initiation factor 3 complexes, regulates MEL-
26 levels in the Caenorhabditis elegans embryo.  Mol Cell Biol
2007, 27:4526-4540.
19. Audhya A, Desai A: Proteomics in Caenorhabditis elegans.  Brief
Funct Genomic Proteomic 2008.
20. Rigaut G, Shevchenko A, Rutz B, Wilm M, Mann M, Seraphin B: A
generic protein purification method for protein complex
characterization and proteome exploration.  Nat Biotechnol
1999, 17:1030-1032.
Additional file 1
Legend for overview of recombineering procedures. Figure legend for 
Additional files 2 and 3.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-119-S1.doc]
Additional file 2
Merged overview of recombineering procedures. A merged figure show-
ing the steps and time involved in recombineering using the original RT 
cassette, modified RT cassette, and galK cassette.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-119-S2.ppt]
Additional file 3
Separate overviews of recombineering procedures. Separate figures 
showing the steps and time involved in recombineering using the original 
RT cassette, modified RT cassette, and galK cassette. These are the same 
figures that are merged in Additional file 2, but provided separately for 
ease of reading or printing.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-119-S3.ppt]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Developmental Biology 2008, 8:119 http://www.biomedcentral.com/1471-213X/8/119
Page 15 of 15
(page number not for citation purposes)
21. Gottschalk A, Almedom RB, Schedletzky T, Anderson SD, Yates JR III,
Schafer WR: Identification and characterization of novel nico-
tinic receptor-associated proteins in Caenorhabditis ele-
gans.  EMBO J 2005, 24:2566-2578.
22. Yang P, Sampson HM, Krause HM: A modified tandem affinity
purification strategy identifies cofactors of the Drosophila
nuclear receptor dHNF4.  Proteomics 2006, 6:927-935.
23. Puig O, Caspary F, Rigaut G, Rutz B, Bouveret E, Bragado-Nilsson E,
Wilm M, Seraphin B: The tandem affinity purification (TAP)
method: a general procedure of protein complex purifica-
tion.  Methods 2001, 24:218-229.
24. Maduro M, Pilgrim D: Identification and cloning of unc-119, a
gene expressed in the Caenorhabditis elegans nervous sys-
tem.  Genetics 1995, 141:977-988.
25. Berezikov E, Bargmann CI, Plasterk RH: Homologous gene target-
ing in Caenorhabditis elegans by biolistic transformation.
Nucleic Acids Res 2004, 32:e40.
26. Timmons L, Court DL, Fire A: Ingestion of bacterially expressed
dsRNAs can produce specific and potent genetic interfer-
ence in Caenorhabditis elegans.  Gene 2001, 263:103-112.